BRIEF-Valeant Pharmaceuticals CEO won't rule out Bausch sale-CNBC
Sept 7 (Reuters) -
* Valeant Pharmaceuticals CEO Joe Papa, speaking on CNBC, said he will 'never say never' on a potential sale of Valeant's Bausch + Lomb business, but is focused on selling non-core assets;
* Papa said the company has not set aside funds for investigations and lawsuits Further company coverage: (Reporting By Rod Nickel)
© Thomson Reuters 2017 All rights reserved.